PLEGRIDY access and reimbursement

Broad formulary access to PLEGRIDY1

Preferred on 2 of the nation’s largest health plans/PBMsa,b

million lives

Express Scripts1

million lives


No generic substitution2

More than 80% of patients pay $0 per month for PLEGRIDY1

  • PLEGRIDY is currently covered for nearly 8 out of 10 commercially insured patients nationwide

Biogen Copay Program

The Biogen Copay Program may lower medication cost to as little as $0 for eligible patients with commercial insurance.c

When cost may be a concern for your patients, Biogen may be able to help them start and continue on a Biogen therapy. We will work with your patients based on their individual needs.

Biogen Support Services offers a variety of different financial and insurance resources, including:

  • Working with insurance companies to clarify and confirm coverage, including assistance with the Prior Authorization process and denied claims
  • Insurance counseling that educates uninsured and underinsured patients on government insurance programs
  • If your patients need assistance with the Affordable Care Act, we can help patients and providers become familiar with insurance options
  • Financial assistance options, including the Biogen Copay Program or other possible financial assistance, where applicable

Please contact your Biogen Access & Reimbursement Manager (ARM) for more information on these resources or call Biogen Support Services at 1-800-456-2255 if you have any questions or concerns about patient access to PLEGRIDY.

a Formulary status alone does not imply comparison of safety, efficacy, or dosage regimens of products for relapsing MS.

b Based on Breakaway Partners, Drug Coverage Analytics, March 12, 2020. Biogen does not endorse any particular plan. Because formularies change and many health plans offer more than 1 formulary, it is important to check directly with the health plan to confirm coverage for individual patients.

c There is an annual cap on the amount of assistance that patients can receive over a one-year period. Federal and state laws and other factors may prevent or otherwise restrict eligibility. People covered by Medicare, Medicaid, the VA/DoD, or any other federal plans are not eligible to enroll. Patients are eligible to enroll in the Biogen Copay Program for as long as it is offered and they are treated with a Biogen relapsing MS medication.